Clinical Next-Generation Sequencing Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: CB6EBCB92E7EEN
Market Monitor Global

Abstracts

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

This report contains market size and forecasts of Clinical Next-Generation Sequencing in Global, including the following market information:

Global Clinical Next-Generation Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Clinical Next-Generation Sequencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Clinical Next-Generation Sequencing include Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech and Qiagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Next-Generation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Next-Generation Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Clinical Next-Generation Sequencing Market Segment Percentages, by Type, 2021 (%)

• Targeted Sequencing
• Exome Sequencing
• Others

Global Clinical Next-Generation Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Clinical Next-Generation Sequencing Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Biopharma Companies
• Academic and Research Organizations
• Others

Global Clinical Next-Generation Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Clinical Next-Generation Sequencing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Clinical Next-Generation Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Clinical Next-Generation Sequencing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• PerkinElmer
• Illumina
• Beckman Coulter
• GATC Biotech
• Qiagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clinical Next-Generation Sequencing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clinical Next-Generation Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLINICAL NEXT-GENERATION SEQUENCING OVERALL MARKET SIZE

2.1 Global Clinical Next-Generation Sequencing Market Size: 2021 VS 2028
2.2 Global Clinical Next-Generation Sequencing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clinical Next-Generation Sequencing Players in Global Market
3.2 Top Global Clinical Next-Generation Sequencing Companies Ranked by Revenue
3.3 Global Clinical Next-Generation Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Clinical Next-Generation Sequencing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clinical Next-Generation Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Next-Generation Sequencing Players in Global Market
  3.6.1 List of Global Tier 1 Clinical Next-Generation Sequencing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clinical Next-Generation Sequencing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Clinical Next-Generation Sequencing Market Size Markets, 2021 & 2028
  4.1.2 Targeted Sequencing
  4.1.3 Exome Sequencing
  4.1.4 Others
4.2 By Type - Global Clinical Next-Generation Sequencing Revenue & Forecasts
  4.2.1 By Type - Global Clinical Next-Generation Sequencing Revenue, 2017-2022
  4.2.2 By Type - Global Clinical Next-Generation Sequencing Revenue, 2023-2028
  4.2.3 By Type - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clinical Next-Generation Sequencing Market Size, 2021 & 2028
  5.1.2 Hospitals and Clinics
  5.1.3 Biopharma Companies
  5.1.4 Academic and Research Organizations
  5.1.5 Others
5.2 By Application - Global Clinical Next-Generation Sequencing Revenue & Forecasts
  5.2.1 By Application - Global Clinical Next-Generation Sequencing Revenue, 2017-2022
  5.2.2 By Application - Global Clinical Next-Generation Sequencing Revenue, 2023-2028
  5.2.3 By Application - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Clinical Next-Generation Sequencing Market Size, 2021 & 2028
6.2 By Region - Global Clinical Next-Generation Sequencing Revenue & Forecasts
  6.2.1 By Region - Global Clinical Next-Generation Sequencing Revenue, 2017-2022
  6.2.2 By Region - Global Clinical Next-Generation Sequencing Revenue, 2023-2028
  6.2.3 By Region - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Clinical Next-Generation Sequencing Revenue, 2017-2028
  6.3.2 US Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.3.3 Canada Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.3.4 Mexico Clinical Next-Generation Sequencing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Clinical Next-Generation Sequencing Revenue, 2017-2028
  6.4.2 Germany Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.3 France Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.4 U.K. Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.5 Italy Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.6 Russia Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.7 Nordic Countries Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.4.8 Benelux Clinical Next-Generation Sequencing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Clinical Next-Generation Sequencing Revenue, 2017-2028
  6.5.2 China Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.5.3 Japan Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.5.4 South Korea Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.5.5 Southeast Asia Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.5.6 India Clinical Next-Generation Sequencing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Clinical Next-Generation Sequencing Revenue, 2017-2028
  6.6.2 Brazil Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.6.3 Argentina Clinical Next-Generation Sequencing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clinical Next-Generation Sequencing Revenue, 2017-2028
  6.7.2 Turkey Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.7.3 Israel Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.7.4 Saudi Arabia Clinical Next-Generation Sequencing Market Size, 2017-2028
  6.7.5 UAE Clinical Next-Generation Sequencing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Major Product Offerings
  7.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 PerkinElmer
  7.2.1 PerkinElmer Corporate Summary
  7.2.2 PerkinElmer Business Overview
  7.2.3 PerkinElmer Clinical Next-Generation Sequencing Major Product Offerings
  7.2.4 PerkinElmer Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.2.5 PerkinElmer Key News
7.3 Illumina
  7.3.1 Illumina Corporate Summary
  7.3.2 Illumina Business Overview
  7.3.3 Illumina Clinical Next-Generation Sequencing Major Product Offerings
  7.3.4 Illumina Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.3.5 Illumina Key News
7.4 Beckman Coulter
  7.4.1 Beckman Coulter Corporate Summary
  7.4.2 Beckman Coulter Business Overview
  7.4.3 Beckman Coulter Clinical Next-Generation Sequencing Major Product Offerings
  7.4.4 Beckman Coulter Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.4.5 Beckman Coulter Key News
7.5 GATC Biotech
  7.5.1 GATC Biotech Corporate Summary
  7.5.2 GATC Biotech Business Overview
  7.5.3 GATC Biotech Clinical Next-Generation Sequencing Major Product Offerings
  7.5.4 GATC Biotech Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.5.5 GATC Biotech Key News
7.6 Qiagen
  7.6.1 Qiagen Corporate Summary
  7.6.2 Qiagen Business Overview
  7.6.3 Qiagen Clinical Next-Generation Sequencing Major Product Offerings
  7.6.4 Qiagen Clinical Next-Generation Sequencing Revenue in Global Market (2017-2022)
  7.6.5 Qiagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clinical Next-Generation Sequencing Market Opportunities & Trends in Global Market
Table 2. Clinical Next-Generation Sequencing Market Drivers in Global Market
Table 3. Clinical Next-Generation Sequencing Market Restraints in Global Market
Table 4. Key Players of Clinical Next-Generation Sequencing in Global Market
Table 5. Top Clinical Next-Generation Sequencing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Clinical Next-Generation Sequencing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Clinical Next-Generation Sequencing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Clinical Next-Generation Sequencing Product Type
Table 9. List of Global Tier 1 Clinical Next-Generation Sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Next-Generation Sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Clinical Next-Generation Sequencing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Clinical Next-Generation Sequencing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Clinical Next-Generation Sequencing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Clinical Next-Generation Sequencing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Clinical Next-Generation Sequencing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Clinical Next-Generation Sequencing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product Offerings
Table 32. Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)
Table 33. PerkinElmer Corporate Summary
Table 34. PerkinElmer Clinical Next-Generation Sequencing Product Offerings
Table 35. PerkinElmer Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)
Table 36. Illumina Corporate Summary
Table 37. Illumina Clinical Next-Generation Sequencing Product Offerings
Table 38. Illumina Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Clinical Next-Generation Sequencing Product Offerings
Table 41. Beckman Coulter Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)
Table 42. GATC Biotech Corporate Summary
Table 43. GATC Biotech Clinical Next-Generation Sequencing Product Offerings
Table 44. GATC Biotech Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)
Table 45. Qiagen Corporate Summary
Table 46. Qiagen Clinical Next-Generation Sequencing Product Offerings
Table 47. Qiagen Clinical Next-Generation Sequencing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Clinical Next-Generation Sequencing Segment by Type in 2021
Figure 2. Clinical Next-Generation Sequencing Segment by Application in 2021
Figure 3. Global Clinical Next-Generation Sequencing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Clinical Next-Generation Sequencing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Clinical Next-Generation Sequencing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2021
Figure 8. By Type - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 12. US Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 16. Germany Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 17. France Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 24. China Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 28. India Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 30. Brazil Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Clinical Next-Generation Sequencing Revenue Market Share, 2017-2028
Figure 33. Turkey Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Clinical Next-Generation Sequencing Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PerkinElmer Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Illumina Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Coulter Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GATC Biotech Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Qiagen Clinical Next-Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)